Trial Profile

A registrational trial assessing CPL36

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 12 Jul 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs CPL 500036 (Primary)
Indications Drug-induced dyskinesia; Schizophrenia
Focus Registrational; Therapeutic Use
Sponsors Celon Pharma

Most Recent Events

12 Jul 2024 New trial record
09 Jul 2024 According to Celon Pharma media release, management plans to discuss encouraging results from phase 2 trial trial with regulatory agencies to advance CPL36 towards registrational trials and global marketing approvals

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com